Mabpharm Ltd (SEHK:2181)

APAC company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - 2181

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - 2181

  • Market CapHKD0.000m
  • SymbolSEHK:2181
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINKYG5780F1046

Company Profile

Mabpharm Ltd is a biopharmaceutical company. It is engaged in the research, development, and production of new drugs and biosimilar for cancers and autoimmune diseases. The firm's core products include CMAB008 (infliximab), CMAB007 (omalizumab), and CMAB009 (cetuximab).

Latest 2181 news

Currently there for this company. Visit our news hub for other news .